Literature DB >> 24247857

Apathy is associated with increased amyloid burden in mild cognitive impairment.

Gad A Marshall, Nancy J Donovan, Natacha Lorius, Christopher M Gidicsin, Jacqueline Maye, Lesley C Pepin, J Alex Becker, Rebecca E Amariglio, Dorene M Rentz, Reisa A Sperling, Keith A Johnson.   

Abstract

Apathy is the most common neuropsychiatric symptom in mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia. The authors sought to determine whether apathy is associated with cortical amyloid burden, as measured by Pittsburgh Compound B (PiB) positron emission tomography (PET), and regional hypometabolism, measured by 18F-fluorodeoxyglocuse (FDG) PET in MCI. The authors found a significant association between increased apathy (lower Apathy Evaluation Scale score) and greater cortical PiB retention independent of age, but no significant association between apathy and regional FDG metabolism. These results suggest that increased apathy is associated with greater amyloid burden but not regional hypometabolism in MCI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24247857      PMCID: PMC3957217          DOI: 10.1176/appi.neuropsych.12060156

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  39 in total

1.  Neuropathologic correlates of apathy in Alzheimer's disease.

Authors:  Gad A Marshall; Lynn A Fairbanks; Sibel Tekin; Harry V Vinters; Jeffrey L Cummings
Journal:  Dement Geriatr Cogn Disord       Date:  2006-01-02       Impact factor: 2.959

2.  Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

Authors:  Keith A Johnson; Matt Gregas; John A Becker; Catherine Kinnecom; David H Salat; Erin K Moran; Erin E Smith; Jonathan Rosand; Dorene M Rentz; William E Klunk; Chester A Mathis; Julie C Price; Steven T Dekosky; Alan J Fischman; Steven M Greenberg
Journal:  Ann Neurol       Date:  2007-09       Impact factor: 10.422

3.  Neuropathologic features of amnestic mild cognitive impairment.

Authors:  Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Kris A Johnson; David S Knopman; Bradley F Boeve; Gregory A Jicha; Robert J Ivnik; Glenn E Smith; Eric G Tangalos; Heiko Braak; Emre Kokmen
Journal:  Arch Neurol       Date:  2006-05

4.  Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study.

Authors:  Philippe H Robert; Claudine Berr; Magali Volteau; Christelle Bertogliati; Michel Benoit; M Sarazin; Sylvie Legrain; Bruno Dubois
Journal:  Clin Neurol Neurosurg       Date:  2006-03-29       Impact factor: 1.876

5.  Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

Authors:  Julie C Price; William E Klunk; Brian J Lopresti; Xueling Lu; Jessica A Hoge; Scott K Ziolko; Daniel P Holt; Carolyn C Meltzer; Steven T DeKosky; Chester A Mathis
Journal:  J Cereb Blood Flow Metab       Date:  2005-11       Impact factor: 6.200

6.  Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

Authors:  D A Bennett; J A Schneider; J L Bienias; D A Evans; R S Wilson
Journal:  Neurology       Date:  2005-03-08       Impact factor: 9.910

7.  Positron emission tomography metabolic correlates of apathy in Alzheimer disease.

Authors:  Gad A Marshall; Lorena Monserratt; Dylan Harwood; Mark Mandelkern; Jeffrey L Cummings; David L Sultzer
Journal:  Arch Neurol       Date:  2007-07

8.  Imaging beta-amyloid burden in aging and dementia.

Authors:  C C Rowe; S Ng; U Ackermann; S J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; P Maruff; D Darby; C Smith; M Woodward; J Merory; H Tochon-Danguy; G O'Keefe; W E Klunk; C A Mathis; J C Price; C L Masters; V L Villemagne
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

9.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

Authors:  Clifford R Jack; Val J Lowe; Matthew L Senjem; Stephen D Weigand; Bradley J Kemp; Maria M Shiung; David S Knopman; Bradley F Boeve; William E Klunk; Chester A Mathis; Ronald C Petersen
Journal:  Brain       Date:  2008-02-07       Impact factor: 13.501

Review 10.  Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature.

Authors:  Liana G Apostolova; Jeffrey L Cummings
Journal:  Dement Geriatr Cogn Disord       Date:  2007-12-14       Impact factor: 2.959

View more
  25 in total

1.  Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults.

Authors:  Miranka Wirth; Claudia M Haase; Sylvia Villeneuve; Jacob Vogel; William J Jagust
Journal:  Neurobiol Aging       Date:  2014-02-20       Impact factor: 4.673

Review 2.  The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.

Authors:  David S Knopman; Samantha Budd Haeberlein; Maria C Carrillo; James A Hendrix; Geoff Kerchner; Richard Margolin; Paul Maruff; David S Miller; Gary Tong; Maria B Tome; Melissa E Murray; Peter T Nelson; Mary Sano; Niklas Mattsson; David L Sultzer; Thomas J Montine; Clifford R Jack; Hartmuth Kolb; Ronald C Petersen; Prashanthi Vemuri; Megan Zoschg Canniere; Julie A Schneider; Susan M Resnick; Gary Romano; Argonde Corien van Harten; David A Wolk; Lisa J Bain; Eric Siemers
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

Review 3.  Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?

Authors:  Paul B Rosenberg; Milap A Nowrangi; Constantine G Lyketsos
Journal:  Mol Aspects Med       Date:  2015-06-03

4.  Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.

Authors:  Matthias Brendel; Oliver Pogarell; Guoming Xiong; Andreas Delker; Peter Bartenstein; Axel Rominger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-29       Impact factor: 9.236

Review 5.  Clinical workout for the early detection of cognitive decline and dementia.

Authors:  M Tsolaki
Journal:  Eur J Clin Nutr       Date:  2014-10-01       Impact factor: 4.016

6.  The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.

Authors:  Brendan J Guercio; Nancy J Donovan; Catherine E Munro; Sarah L Aghjayan; Sarah E Wigman; Joseph J Locascio; Rebecca E Amariglio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

7.  Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.

Authors:  Nancy J Donovan; David C Hsu; Alexander S Dagley; Aaron P Schultz; Rebecca E Amariglio; Elizabeth C Mormino; Olivia I Okereke; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals.

Authors:  Brendan J Guercio; Nancy J Donovan; Andrew Ward; Aaron Schultz; Natacha Lorius; Rebecca E Amariglio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014-11-10       Impact factor: 2.198

9.  Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.

Authors:  Jennifer R Gatchel; Nancy J Donovan; Joseph J Locascio; J Alex Becker; Dorene M Rentz; Reisa A Sperling; Keith A Johnson; Gad A Marshall
Journal:  Am J Geriatr Psychiatry       Date:  2017-01-04       Impact factor: 4.105

10.  Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia.

Authors:  Gad A Marshall; Jennifer R Gatchel; Nancy J Donovan; Martha C Muniz; Aaron P Schultz; J Alex Becker; Jasmeer P Chhatwal; Bernard J Hanseeuw; Kathryn V Papp; Rebecca E Amariglio; Dorene M Rentz; Reisa A Sperling; Keith A Johnson
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.